Latest News and Press Releases

Boston, Oct. 31, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Chinese Market for DNA Sequencing” is projected to grow from $1.2 billion in 2025 to $3.1 billion by...

The company aims to uncover molecular and cellular signatures associated with disease onset, progression, and risk, often before clinical symptoms appear.

RetinalGenix Technologies and RGEN Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

Biognosys launches metabolomics/lipidomics services with biocrates, expanding multiomics CRO offerings for drug discovery and clinical research.

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms

APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life...

Codetta Bio debuts its Concerto™ System at AACR 2025—an all-in-one multi-omics platform with early access for 50 pioneering researchers.

Codetta Bio debuts its Concerto™ System at AACR 2025, enabling simultaneous protein, DNA & RNA quantification from one sample. Visit booth 2445.

Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3...